FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/067643 [Registered on: 20/05/2024] Trial Registered Prospectively
Last Modified On: 20/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Diagnostic
Dentistry 
Study Design  Other 
Public Title of Study   Effect on Interleukin-6 levels in saliva of the diabetic patients having periapical lesion 
Scientific Title of Study   Evaluation of Salivary Interleukin-6 levels in Diabetic patients with periapical lesion-An In Vivo Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rashi Bansal 
Designation  MDS(Postgraduate) 
Affiliation  ITS Dental College Hospital And Research Centre, Greater Noida 
Address  Room no 7, Department of Conservative Dentistry and Endodontics, ITS Dental College Hospital And Research Centre, 47, Knowledge Park III, Greater Noida

Gautam Buddha Nagar
UTTAR PRADESH
201308
India 
Phone  9679469452  
Fax    
Email  rashibansal854@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Manju Kumari 
Designation  Professor 
Affiliation  ITS Dental College Hospital And Research Centre, Greater Noida 
Address  Room no 7, Department of Conservative Dentistry and Endodontics, ITS Dental College Hospital And Research Centre, 47, Knowledge Park III, Greater Noida

Gautam Buddha Nagar
UTTAR PRADESH
201308
India 
Phone  9811056881  
Fax    
Email  dr.manjukumari.dntl.gn@its.edu.in  
 
Details of Contact Person
Public Query
 
Name  Dr Rashi Bansal 
Designation  MDS(Postgraduate) 
Affiliation  ITS Dental College Hospital And Research Centre, Greater Noida 
Address  Room no 7, Department of Conservative Dentistry and Endodontics, ITS Dental College Hospital And Research Centre, 47, Knowledge Park III, Greater Noida

Gautam Buddha Nagar
UTTAR PRADESH
201308
India 
Phone  9679469452  
Fax    
Email  rashibansal854@gmail.com  
 
Source of Monetary or Material Support  
Room no 7, Department of Conservative Dentistry and Endodontics, ITS Dental College Hospital and Research Centre,47, Knowledge park III, Greater noida- 201308,Uttar Pradesh , India 
 
Primary Sponsor  
Name  ITS Dental College Hospital And Research Centre 
Address  Room no 7 Department of Conservative Dentistry and Endodontics ITS Dental College Greater Noida 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rashi Bansal  ITS Dental College Hospital and Research Centre, Greater Noida  Room no 7, Department of Conservative and Endodontics, ITS Dental College and Research Centre, 47,Knowledge Park III, Greater Noida
Gautam Buddha Nagar
UTTAR PRADESH 
9679469452

rashibansal854@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ITS Dental College Hospital and Research Centre Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K044||Acute apical periodontitis of pulpal origin, (2) ICD-10 Condition: E119||Type 2 diabetes mellitus without complications,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  healthy patients with no periapical lesion   This group will evaluate the salivary interleukin-6 levels through ELISA in 15 healthy patients with vital (healthy) tooth indicated for intentional root canal treatment before root canal treatment and after BMP, on the day of obturation. 
Comparator Agent  Healthy patients with periapical lesion   This group will evaluate the salivary interleukin-6 levels through ELISA in 15 healthy patients having periapical radiolucency measuring not more than 4mm diameter before root canal treatment and after BMP, on the day of obturation. 
Intervention  Type 2 Diabetes mellitus with no periapical lesion   This group will evaluate the salivary interleukin-6 levels through ELISA in 15 patients with type 2 diabetes mellitus (patients who are on oral medications with fasting plasma less than 100 mg/dl) without periapical lesion before root canal treatment and after BMP, on the day of obturation. 
Intervention  Type 2 Diabetes mellitus with periapical lesion   This group will evaluate the salivary interleukin- 6 levels through ELISA in 15 patients with type 2 diabetes mellitus (patients who are on oral medications with fasting plasma less than 100 mg/dl) with periapical lesion measuring not more than 4mm diameter before root canal treatment and after BMP,on the day of obturation. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.Patients of either gender and age between 20-65 years
2. Patients with type 2 diabetes mellitus with RBS levels not more than 160 mg/dl
3. Patient with symptomatic/ asymptomatic irreversible pulpitis
4. Patients having healthy periodontal status
5. Patients consenting to participate in the study.
6. Patients with caries will be restored prior to the study.
 
 
ExclusionCriteria 
Details  1. Patients having other systemic diseases such as hypertension, cancer, Obesity, heart diseases, Alzheimer’s disease, pregnant women
2. Any use of medicaments such as anti-inflammatory or antibiotics in past 3 months.
3. Periapical lesion more than 4mm
4.Teeth with periodontal infections
5. Patients having habits like smoking, drinking alcohol etc

 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1. To evaluate and compare the levels of IL-6 before and after the root canal treatment in healthy patients
2. To evaluate and compare the levels of IL-6 before and after the root canal treatment in diabetic patients
 
Baseline(on the day of onset of trial) and after 1 week(post operative) 
 
Secondary Outcome  
Outcome  TimePoints 
To find the effect on IL-6 due to endodontic lesions  Baseline(on the day of onset of trial) & after 1 week(post operative) 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   05/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study will be done to evaluate the interleukin- 6 levels in the diabetic patients with periapical lesion. The forthcoming in vivo study will be carried out within the Department of Conservative Dentistry and Endodontics at ITS Dental College and Research Centre in Greater Noida, Uttar Pradesh. A total number of 60 patients including healthy and type 2 diabetes mellitus patients of age 20-65 years reporting to the OPD of Department of Conservative Dentistry will be selected as per the inclusion and exclusion criteria. Medical and dental history will be recorded for patients reporting to the Department of Conservative and Endodontics and patients will be selected according to the inclusion criteria in the study. Included patients will be informed about the study and explained in detail about the procedure of the study and requirement for the same.  A preoperative radiograph will be taken to assess the size of Periapical radiolucency which should be less than 4mm. RBS levels will be checked using glucometer when the patient will report in the OPD. OPG will be done to evaluate the periodontal health.
They will be divided into 4 groups.
Group A- 15 patients with type 2 diabetes mellitus (patients who are on oral medications with fasting plasma less than 100 mg/dl) with periapical lesion measuring not more than 4mm
Group B- 15 patients with type 2 diabetes mellitus (patients who are on oral medications with fasting plasma less than 100 mg/dl) without periapical lesion.
Group C – 15 healthy patients having periapical radiolucency measuring not more than 4mm diameter
Group C - 15 healthy patients with vital (healthy) tooth indicated for intentional root canal treatment.
Saliva will be collected before the treatment.
Saliva will be collected after BMP, on the day of obturation.
Saliva will be tested through ELISA for the interleukin 6 levels.
 
Close